2023
DOI: 10.3389/fpubh.2023.1171033
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: Occupational exposure and cardiometabolic disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
(10 reference statements)
0
1
0
Order By: Relevance
“…According to the diagnosis criteria of Adult Treatment Panel III (ATP-III) 2 , MetS is usually defined as the presence of three or more of the five common metabolic dysfunctions, i.e., elevated waist circumference (WC), elevated triglycerides (TG), reduced high-density lipoprotein cholesterol (HDL-C), elevated blood pressure (BP), and elevated fasting blood glucose (FBG). However, such a dichotomous definition for MetS, although helpful to identify certain populations at disproportionate future risk for CVDs 5 , 6 , cannot reflect the severity of MetS, which has challenged its applications in tracking the progression of CVD risk and hence preventing CVDs. Previous studies have developed a continuous MetS score in western countries to determine the MetS severity, which was considered a compelling means of motivating patients that may feel empowered by a decrease in score 7 , 8 .…”
Section: Introductionmentioning
confidence: 99%
“…According to the diagnosis criteria of Adult Treatment Panel III (ATP-III) 2 , MetS is usually defined as the presence of three or more of the five common metabolic dysfunctions, i.e., elevated waist circumference (WC), elevated triglycerides (TG), reduced high-density lipoprotein cholesterol (HDL-C), elevated blood pressure (BP), and elevated fasting blood glucose (FBG). However, such a dichotomous definition for MetS, although helpful to identify certain populations at disproportionate future risk for CVDs 5 , 6 , cannot reflect the severity of MetS, which has challenged its applications in tracking the progression of CVD risk and hence preventing CVDs. Previous studies have developed a continuous MetS score in western countries to determine the MetS severity, which was considered a compelling means of motivating patients that may feel empowered by a decrease in score 7 , 8 .…”
Section: Introductionmentioning
confidence: 99%